Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
55.4M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
16.8M
-
Shares change
-
+67K
-
Total reported value, excl. options
-
$95.7M
-
Value change
-
+$387K
-
Put/Call ratio
-
1.02
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$5.71
Significant Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) as of Q4 2022
53 filings reported holding OMGAQ - Omega Therapeutics, Inc. - COMMON STOCK as of Q4 2022.
Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.8M shares
of 55.4M outstanding shares and own 30.29% of the company stock.
Largest 10 shareholders include FMR LLC (4.6M shares), HarbourVest Partners LLC (2.65M shares), Artal Group S.A. (2.27M shares), STATE OF WISCONSIN INVESTMENT BOARD (1.86M shares), CHI Advisors LLC (1.06M shares), VANGUARD GROUP INC (976K shares), PLATINUM INVESTMENT MANAGEMENT LTD (584K shares), BlackRock Inc. (574K shares), Laurion Capital Management LP (433K shares), and 72 Investment Holdings, LLC (353K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.